News

"Reaserch Review: A New Drug to Combat PDR"
By Paul M. Karpecki, OD, and Diana L. Shechtman, OD

Press Releases

Vitreoretinal Technologies, Inc. Announces the Enrollment of First Patients for its Phase III Clinical Trial for Vitreosolve^® for Diabetic Retinopathy Patients in the US and India

Vitreoretinal Technologies Raises $8.8 Million in a Recent Financing

Events